Articles

  • Oct 19, 2023 | erj.ersjournals.com | Christine Bear |Felix Ratjen

    AcknowledgementsThe authors acknowledge assistance in proofreading from Tarini Gunawardena, Project Manager for CFIT (The Programme for Individualized Cystic Fibrosis Therapy, SickKids Hospital and Cystic Fibrosis Canada). FootnotesConflict of interest: F. Ratjen acts as a consultant for Vertex Pharmaceuticals. C. Bear has no potential conflicts of interest to disclose. Received August 17, 2023. Accepted August 21, 2023.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →